Lipoprotein release by bacteria: potential factor in bacterial pathogenesis.
Lipoprotein (LP) is a major component of the outer membrane of bacteria in the family Enterobacteriaceae. LP induces proinflammatory cytokine production in macrophages and lethal shock in LPS-responsive and -nonresponsive mice. In this study, the release of LP from growing bacteria was investigated by immuno-dot blot analysis. An immuno-dot blot assay that could detect LP at levels as low as 100 ng/ml was developed. By using this assay, significant levels of LP were detected in culture supernatants of growing Escherichia coli cells. During mid-logarithmic growth, approximately 1 to 1.5 microgram of LP per ml was detected in culture supernatants from E. coli. In contrast, these culture supernatants contained 5 to 6 microgram/ml of lipopolysaccharide (LPS). LP release was not unique to E. coli. Salmonella typhimurium, Yersinia enterocolitica, and two pathogenic E. coli strains also released LP during in vitro growth. Treatment of bacteria with the antibiotic ceftazidime significantly enhanced LP release. Culture supernatants from 5-h cultures of E. coli were shown to induce in vitro production of interleukin-6 (IL-6) by macrophages obtained from LPS-nonresponsive C3H/HeJ mice. In contrast, culture supernatants from an E. coli LP-deletion mutant were significantly less efficient at inducing IL-6 production in C3H/HeJ macrophages. These results suggest, for the first time, that LP is released from growing bacteria and that this released LP may play an important role in the induction of cytokine production and pathologic changes associated with gram-negative bacterial infections.
Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas 77555-1070, USA.
H
H
Zhang
D W
DW
Niesel
J W
JW
Peterson
G R
GR
Klimpel
D000818:Animals; D001433:Bacteriolysis / Q000187:drug effects; D017077:Culture Media, Conditioned / Q000737:chemistry / Q000494:pharmacology; D005260:Female; D006090:Gram-Negative Bacteria / Q000378:metabolism* / Q000472:pathogenicity*; D016905:Gram-Negative Bacterial Infections / Q000382:microbiology; D015850:Interleukin-6 / Q000096:biosynthesis; D008074:Lipoproteins / Q000378:metabolism* / Q000502:physiology*; D008264:Macrophages / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008809:Mice, Inbred C3H; D014774:Virulence
D017077:Culture Media, Conditioned; D015850:Interleukin-6; D008074:Lipoproteins